Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Syncope secondary prevention
Introduction
Overview
Overview
Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for a specific time based on the guideline.
Secondary Prevention
Secondary Prevention
- Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for specific time based on the guideline.[1]
| Condition | Time needed for avoidance of driving after syncope |
|---|---|
| Ortosthasis hypotension | 1 month |
| Vasovagal syncope, no syncope in last year | No restriction |
| Vasovagal syncope, 1-6 syncope per year | 1 month |
| Vasovagal syncope, >6 syncope per year | No permission until resolving the symptoms |
| Situational syncope other than cough syncope | 1 month |
| cough syncope, not treated | No permission |
| cough syncope, treaten with cough suppression | 1 month |
| carotid sinus syncope, not treated | No permission |
| carotid sinus syncope, treated with permanent pacemaker | 1 week |
| Non reflex sinus bradycardia syncope, not treated | No permission |
| Non reflex sinus bradycardia syncope,permanent pace maker implantation | 1 week |
| SVT leading syncope, not treated | No permission |
| SVT leading syncope, arrhythmia suppression with medications | 1 month |
| SVT leading syncope, arrhythmia ablation | 1 week |
| LVEF< 35% , suspected arrhythmic syncope without ICD | No permission |
| LVEF< 35% , suspected arrhythmic syncope with ICD | 3 months |
| LVEF> 35%, structural heart disease,VT or VF leading syncope, not treated | No permission |
| LVEF> 35%, structural heart disease,VT or VF leading syncope, treated with ICD implantation and medications | 3 months |
| Syncope due to VT from RVOT, LVOT regions, untreated | No permission |
| Syncope due to VT from RVOT, LVOT regions , treated with ICD implantation and medications | 3 months |
| Syncope of undetermined etiology | 1 month |
References
References
- ↑ Shen, Win-Kuang; Sheldon, Robert S.; Benditt, David G.; Cohen, Mitchell I.; Forman, Daniel E.; Goldberger, Zachary D.; Grubb, Blair P.; Hamdan, Mohamed H.; Krahn, Andrew D.; Link, Mark S.; Olshansky, Brian; Raj, Satish R.; Sandhu, Roopinder Kaur; Sorajja, Dan; Sun, Benjamin C.; Yancy, Clyde W. (2017). “2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society”. Circulation. 136 (5). doi:10.1161/CIR.0000000000000499. ISSN 0009-7322.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Sahar Memar Montazerin, M.D.[3]